Article
Advances and critical concerns with the microfluidic enrichments of circulating tumor cells
7 Aug 2013
Abstract excerpt
Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials. While most enrichment methods for these cells have been conducted through the batch process due to their rarity in blood and the need for large sample volumes, the batch process leads to unavoidable cell loss. Given the heterogenetic features of CTCs, this cell loss may limit the validity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
